This document is a publication of a European patent application (EP3471772A1) filed by Regeneron Pharmaceuticals, Inc. The patent covers "Compositions and Methods for the Depletion of Cells," with specific IPC classifications related to pharmaceutical compositions, cell therapy, and antibodies. The publication date is March 11, 2026.

This publication represents the grant of a patent, not a regulatory rule or enforcement action. It provides intellectual property protection for Regeneron's technology. Compliance officers in the pharmaceutical and biotechnology sectors should note this patent as it may affect research, development, and commercialization strategies related to cell depletion therapies. No immediate compliance actions are required by other entities, but awareness of patented technologies is crucial for avoiding infringement.